Q1. Could you start by giving us a brief overview of your professional background, particularly focusing on your expertise in the industry?

The first half of my career was spent in the OR and cardiac/radiology labs, selling medical devices. The last 16 years have been in the healthcare finance, RCM, or revenue cycle industry, selling technology and services for 3 unique organizations.

Q2. What structural shift in the healthcare revenue cycle landscape is most changing how providers choose technology partners today?  

A couple of things come to mind.  There is a greater appetite for outsourcing and using offshore resources to offset service costs.  This comes at the expense of data security.    The second is the continual search for entry-level FTEs and staffing shortages.  Healthcare is notorious for slow technology adoption, but that may be forced to accelerate consideration of AI applications to address staffing challenges.

Q3. Where does automation materially improve provider margins, and where does it struggle to deliver measurable ROI? 

As I mentioned above, staffing will drive technology adoption.  This is a challenge for hospitals: investing in new technologies that may or may not be vetted for real ROI, so there is investment with less certainty about productivity improvements.

Q4. Where do regulatory, compliance, or data privacy requirements meaningfully constrain margins or scalability, and how do strong operators manage that trade-off? 

I touched on this previously, but strong data security fences are being lowered to allow data sharing. Offshore outsourcing improves margins but may compromise data security or require more extensive consideration of the trade-offs.

Q5. Which provider segment or regional market appears attractive in demand data but proves hardest to scale operationally, and what makes it structurally complex?  

Care management or sharing patient care across disparate EMRs remains a challenge, and patients would benefit most from enabling cross-communication.

Q6. Where is the most underpenetrated growth opportunity within the healthcare administration ecosystem today? 

If operations made more decisions and gave CTOs and IT teams less influence, placing significant emphasis on innovation and improvement, this would accelerate the challenges mentioned above.

Q7. If you were an investor looking at companies within the space, what critical question would you pose to their senior management?  

How are we positioned for both large IDNs, and can we scale down to meet the smaller margins of critical access hospitals?